AU7358098A - Radioisotope concentrator methods and compositions - Google Patents
Radioisotope concentrator methods and compositionsInfo
- Publication number
- AU7358098A AU7358098A AU73580/98A AU7358098A AU7358098A AU 7358098 A AU7358098 A AU 7358098A AU 73580/98 A AU73580/98 A AU 73580/98A AU 7358098 A AU7358098 A AU 7358098A AU 7358098 A AU7358098 A AU 7358098A
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- radioisotope concentrator
- methods
- concentrator methods
- radioisotope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83570797A | 1997-04-10 | 1997-04-10 | |
US08835707 | 1997-04-10 | ||
PCT/US1998/007130 WO1998045443A1 (en) | 1997-04-10 | 1998-04-09 | Radioisotope concentrator methods and compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7358098A true AU7358098A (en) | 1998-10-30 |
Family
ID=25270260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU73580/98A Abandoned AU7358098A (en) | 1997-04-10 | 1998-04-09 | Radioisotope concentrator methods and compositions |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0973902A1 (en) |
JP (1) | JP2001523955A (en) |
AU (1) | AU7358098A (en) |
CA (1) | CA2286860A1 (en) |
WO (1) | WO1998045443A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6586411B1 (en) * | 2000-08-16 | 2003-07-01 | Mayo Foundation For Medical Education And Research | System for monitoring the location of transgenes |
GB0409596D0 (en) * | 2004-04-29 | 2004-06-02 | Crusade Lab Ltd | Novel herpes simplex viruses and uses thereof |
EP1900749A1 (en) | 2006-09-12 | 2008-03-19 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
US9951117B2 (en) | 2010-09-02 | 2018-04-24 | Mayo Foundation For Medical Education And Research | Vesicular stomatitis viruses |
WO2012031137A2 (en) | 2010-09-02 | 2012-03-08 | Mayo Foundation For Medical Education And Research | Vesicular stomatitis viruses |
KR101504012B1 (en) | 2013-06-27 | 2015-03-18 | 장관순 | Intravenous delivery device |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69433343D1 (en) * | 1993-12-07 | 2003-12-24 | Neorx Corp | PRETARGETING METHOD AND MEANS |
US6391579B1 (en) * | 1996-02-01 | 2002-05-21 | Albert Einstein College Of Medicine Of Yeshiva University | Thyroid sodium/iodide symporter and nucleic acid encoding same |
-
1998
- 1998-04-09 WO PCT/US1998/007130 patent/WO1998045443A1/en not_active Application Discontinuation
- 1998-04-09 AU AU73580/98A patent/AU7358098A/en not_active Abandoned
- 1998-04-09 CA CA002286860A patent/CA2286860A1/en not_active Abandoned
- 1998-04-09 EP EP98920832A patent/EP0973902A1/en not_active Withdrawn
- 1998-04-09 JP JP54312898A patent/JP2001523955A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1998045443A1 (en) | 1998-10-15 |
JP2001523955A (en) | 2001-11-27 |
EP0973902A1 (en) | 2000-01-26 |
CA2286860A1 (en) | 1998-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3767097A (en) | Shampoo compositions and method | |
HUP0001154A3 (en) | 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same | |
ZA989400B (en) | Method and composition | |
AU4623997A (en) | Shampoo composition | |
EP1056456A4 (en) | R-lansoprazole compositions and methods | |
AU4817797A (en) | Mass particle encapsulation and electroforming | |
AU2972597A (en) | Compositions and uses thereof | |
AU5335798A (en) | Stomatic composition | |
EP1056457A4 (en) | S-lansoprazole compositions and methods | |
AU8747498A (en) | Food-preservative composition | |
MX9802476A (en) | Coating compositions for development electrodes and methods thereof | |
PL331423A1 (en) | Muporocin and chlorohexidrin containing compositions | |
AU9301998A (en) | Composition and methods using galectin-1 | |
EP1073333A4 (en) | S-rabeprazole compositions and methods | |
AU4068299A (en) | Bismuth-213 generator and uses thereof | |
AU1750797A (en) | Compositions and methods for mediating cell cycle progression | |
AU8121998A (en) | Composition | |
AU7134598A (en) | Plant propagation compositions and methods | |
AU7358098A (en) | Radioisotope concentrator methods and compositions | |
AU3200197A (en) | New composition and methods | |
AU2346800A (en) | Compositions and methods using cell fusion | |
AUPO982097A0 (en) | Methods and compositions for use therein | |
AU3900499A (en) | (+)-hydroxyrisperidone compositions and methods | |
EP0930361A4 (en) | Cell compositions | |
AU9374498A (en) | Makeup composition and method |